Supplementary Figure S1 from Safety and Efficacy of Tarlatamab in Patients with Neuroendocrine Prostate Cancer: Results from the Phase 1b DeLLpro-300 Study — Rahul Aggarwal (2025) | RDL Network
Supplementary Figure S1 from Safety and Efficacy of Tarlatamab in Patients with Neuroendocrine Prostate Cancer: Results from the Phase 1b DeLLpro-300 Study
Rahul Aggarwal, Sylvie Rottey, Alice Bernard‐Tessier, Begoña Mellado, Takeo Kosaka, Walter M. Stadler, Lisa G. Horvath, Richard Greil, Bert H. O’Neil, Bilal A. Siddiqui, Thomas Bauernhofer, Mehmet Asım Bilen, Ferry A.L.M. Eskens, Shahneen Sandhu, Crystal Shaw, Changqing Ju, Benjamin E. Decato, Brian Yu, Ana M. Aparicio
Rahul Aggarwal, Sylvie Rottey, Alice Bernard‐Tessier, Begoña Mellado, Takeo Kosaka, Walter M. Stadler, Lisa G. Horvath, Richard Greil, Bert H. O’Neil, Bilal A. Siddiqui, Thomas Bauernhofer, Mehmet Asım Bilen, Ferry A.L.M. Eskens, Shahneen Sandhu, Crystal Shaw, Changqing Ju, Benjamin E. Decato, Brian Yu, Ana M. Aparicio
Rahul Aggarwal, Sylvie Rottey, Alice Bernard‐Tessier, Begoña Mellado, Takeo Kosaka, Walter M. Stadler, Lisa G. Horvath, Richard Greil, Bert H. O’Neil, Bilal A. Siddiqui, Thomas Bauernhofer, Mehmet Asım Bilen, Ferry A.L.M. Eskens, Shahneen Sandhu, Crystal Shaw, Changqing Ju, Benjamin E. Decato, Brian Yu, Ana M. Aparicio
Rahul Aggarwal, Sylvie Rottey, Alice Bernard‐Tessier, Begoña Mellado, Takeo Kosaka, Walter M. Stadler, Lisa G. Horvath, Richard Greil, Bert H. O’Neil, Bilal A. Siddiqui, Thomas Bauernhofer, Mehmet Asım Bilen, Ferry A.L.M. Eskens, Shahneen Sandhu, Crystal Shaw, Changqing Ju, Benjamin E. Decato, Brian Yu, Ana M. Aparicio
Rahul Aggarwal, Sylvie Rottey, Alice Bernard‐Tessier, Begoña Mellado, Takeo Kosaka, Walter M. Stadler, Lisa G. Horvath, Richard Greil, Bert H. O’Neil, Bilal A. Siddiqui, Thomas Bauernhofer, Mehmet Asım Bilen, Ferry A.L.M. Eskens, Shahneen Sandhu, Crystal Shaw, Changqing Ju, Benjamin E. Decato, Brian Yu, Ana M. Aparicio
Discussion(0)
No comments yet. Be the first to comment.